These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24090643)

  • 21. A before-and-after study of fracture risk reporting and osteoporosis treatment initiation.
    Leslie WD; Morin S; Lix LM
    Ann Intern Med; 2010 Nov; 153(9):580-6. PubMed ID: 21041577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines.
    Bolland MJ; Grey A
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1856-60. PubMed ID: 20147581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Number of osteoporotic sites and fracture risk assessment: a cohort study from the Manitoba Bone Density Program.
    Leslie WD; Tsang JF; Caetano PA; Lix LM;
    J Bone Miner Res; 2007 Mar; 22(3):476-83. PubMed ID: 17144788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and treatment of osteoporosis after hip fracture: comparison of sex and race.
    Antonelli M; Einstadter D; Magrey M
    J Clin Densitom; 2014; 17(4):479-83. PubMed ID: 24657109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice.
    Seuffert P; Sagebien CA; McDonnell M; O'Hara DA
    Arch Osteoporos; 2016; 11():10. PubMed ID: 26847628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fracture risk prediction using phalangeal bone mineral density or FRAX(®)?-A Danish cohort study on men and women.
    Friis-Holmberg T; Rubin KH; Brixen K; Tolstrup JS; Bech M
    J Clin Densitom; 2014; 17(1):7-15. PubMed ID: 23623379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice.
    Kyriakos G; Vidal-Casariego A; Fernández-Martínez MN; Blanco-Suárez MD; Ballesteros-Pomar MD; Cano-Rodríguez I
    J Clin Densitom; 2015; 18(4):533-8. PubMed ID: 26343823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines.
    Baddoura R; Awada H; Okais J; Salamoun M; Ayoub G; Ziadé N; El Hajj-Fuleihan G
    Osteoporos Int; 2006; 17(7):1111-5. PubMed ID: 16758146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FRAX® counseling for bone health behavior change in women 50 years of age and older.
    Dunniway DL; Camune B; Baldwin K; Crane JK
    J Am Acad Nurse Pract; 2012 Jun; 24(6):382-9. PubMed ID: 22672490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmenopausal osteoporosis: fracture risk and prevention.
    Kaunitz AM; McClung MR; Feldman RG; Wysocki S
    J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of FRAX-based osteoporosis intervention using real world data.
    Goldshtein I; Ish-Shalom S; Leshno M
    Bone; 2017 Oct; 103():318-324. PubMed ID: 28778597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low bone mineral density and fracture burden in postmenopausal women.
    Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
    CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fracture risk prediction in outpatients from Krakow Region using FRAX tool versus fracture risk in 11-year follow-up.
    Czerwiński E; Borowy P; Kumorek A; Amarowicz J; Górkiewicz M; Milert A
    Ortop Traumatol Rehabil; 2013; 15(6):617-28. PubMed ID: 24662908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis.
    Frost ML; Blake GM; Fogelman I
    J Bone Miner Res; 2001 Feb; 16(2):406-16. PubMed ID: 11204441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
    Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
    J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone mineral density and association of osteoarthritis with fracture risk.
    Chan MY; Center JR; Eisman JA; Nguyen TV
    Osteoarthritis Cartilage; 2014 Sep; 22(9):1251-8. PubMed ID: 25042553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on childhood bone health: mineral accrual, assessment and treatment.
    Sopher AB; Fennoy I; Oberfield SE
    Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):35-40. PubMed ID: 25517023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
    Yu R; Leung J; Woo J
    J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacy-based bone mass measurement to assess osteoporosis risk.
    Elliott ME; Meek PD; Kanous NL; Schill GR; Weinswig PA; Bohlman JP; Zimpel CL; Jensen BC; Walters DR; Sutter SL; Peterson AN; Peterson RM; Binkley NC
    Ann Pharmacother; 2002 Apr; 36(4):571-7. PubMed ID: 11918501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporotic fractures, DXA, and fracture risk assessment: meeting future challenges in the Eastern Mediterranean Region.
    Baddoura R; Hoteit M; El-Hajj Fuleihan G
    J Clin Densitom; 2011; 14(4):384-94. PubMed ID: 21839659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.